ABL Bio Inc. (KOSDAQ:298380)
33,000
-3,800 (-10.33%)
Apr 2, 2025, 3:30 PM KST
ABL Bio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 56,289 | 28,064 | 25,136 | 21,589 |
Short-Term Investments | 80,852 | 8,026 | 7,611 | 74.38 |
Trading Asset Securities | 4,371 | 35,075 | 45,570 | 22,058 |
Cash & Short-Term Investments | 141,512 | 71,165 | 78,317 | 43,721 |
Cash Growth | 98.85% | -9.13% | 79.13% | - |
Other Receivables | 627.21 | 60.89 | 451.78 | 83.87 |
Receivables | 827.21 | 260.89 | 451.78 | 83.87 |
Prepaid Expenses | 1,416 | 1,779 | 819.53 | 563.08 |
Other Current Assets | 396.07 | 2,333 | 946.34 | 1,105 |
Total Current Assets | 144,151 | 75,539 | 80,535 | 45,472 |
Property, Plant & Equipment | 85,406 | 76,035 | 6,713 | 3,304 |
Long-Term Investments | -0 | 2,743 | 27,634 | 13,503 |
Other Intangible Assets | 2,390 | 2,534 | 2,610 | 2,556 |
Other Long-Term Assets | 27.99 | 3,294 | 67,689 | 617.29 |
Total Assets | 231,976 | 160,144 | 185,181 | 65,453 |
Accrued Expenses | 397.73 | 165.07 | 131.53 | 15.98 |
Short-Term Debt | 43,000 | - | - | - |
Current Portion of Leases | 637.49 | 784.47 | 1,167 | 502.03 |
Other Current Liabilities | 19,326 | 40,810 | 70,874 | 8,232 |
Total Current Liabilities | 63,361 | 41,760 | 72,172 | 8,750 |
Long-Term Debt | - | 43,000 | 40,000 | - |
Long-Term Leases | 25.8 | 153.53 | 668.93 | 72.32 |
Other Long-Term Liabilities | 890.74 | 1,152 | 2,826 | 677.05 |
Total Liabilities | 64,696 | 86,065 | 115,667 | 9,500 |
Common Stock | 24,141 | 23,946 | 23,894 | 23,562 |
Additional Paid-In Capital | 510,998 | 363,760 | 361,173 | 348,732 |
Retained Earnings | -398,304 | -342,345 | -339,134 | -342,535 |
Comprehensive Income & Other | 27,556 | 28,718 | 23,580 | 26,194 |
Total Common Equity | 164,391 | 74,079 | 69,513 | 55,953 |
Shareholders' Equity | 167,280 | 74,079 | 69,513 | 55,953 |
Total Liabilities & Equity | 231,976 | 160,144 | 185,181 | 65,453 |
Total Debt | 43,663 | 43,938 | 41,836 | 574.35 |
Net Cash (Debt) | 97,849 | 27,227 | 36,481 | 43,147 |
Net Cash Growth | 259.38% | -25.37% | -15.45% | - |
Net Cash Per Share | 2037.61 | 569.08 | 766.95 | 918.60 |
Filing Date Shares Outstanding | 48.28 | 47.89 | 47.79 | 47.12 |
Total Common Shares Outstanding | 48.28 | 47.89 | 47.79 | 47.12 |
Working Capital | 80,791 | 33,779 | 8,362 | 36,722 |
Book Value Per Share | 3404.81 | 1546.78 | 1454.61 | 1187.37 |
Tangible Book Value | 162,000 | 71,545 | 66,903 | 53,397 |
Tangible Book Value Per Share | 3355.30 | 1493.87 | 1400.00 | 1133.14 |
Land | 1,361 | 1,194 | 1,173 | - |
Buildings | 1,361 | 1,194 | 1,173 | - |
Machinery | 8,290 | 7,352 | 6,540 | 5,809 |
Construction In Progress | 79,806 | 70,491 | - | - |
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.